tiprankstipranks
Mydecine Innovations Group, Inc. (TSE:MYCO)
:MYCO
Canadian Market

Mydecine Innovations Group (MYCO) Income Statement

Compare
97 Followers

Mydecine Innovations Group Income Statement

Last quarter (Q3 2024), Mydecine Innovations Group's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Mydecine Innovations Group's net income was $-1.99M. See Mydecine Innovations Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ ―$ ―$ 7.49K$ 2.62K$ 31.52K
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 9.88K$ 128.86K$ 235.18K$ 57.08K$ 46.39K
EBITDA
$ -19.63M$ -16.20M$ -23.14M$ -26.64M$ -21.30M
Operating Income
$ -9.55M$ -16.39M$ -22.68M$ -11.46M$ -3.39M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -20.95M$ -11.57M$ -28.90M$ -26.95M$ -21.43M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Mydecine Innovations Group Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis